Product Usage:
THIS PRODUCT IS INTENDED FOR RESEARCH PURPOSES ONLY.
All product information available on this website is for educational purposes only. This product is not intended for consumption or bodily introduction of any kind. It should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
GLP1-T
$150.00 - $400.00
- •Dual GLP-1/GIP receptor agonism
- •Superior to single-receptor agonists in studies
- •Enhanced weight reduction and glycemic control
- •Synergistic insulin secretion modulation
- •Cardiovascular risk marker improvement
- •Broadest dosage range available (5-120mg)
Purchase Option
Recommended add-on
Reconstitution Solution — for Laboratory Use
Reconstitution Solution
30 mL — For Laboratory Use
$25.00
DIA-39-C20 is a dual incretin receptor agonist targeting GLP-1 and GIP receptors. It modulates glucose homeostasis and insulin secretion with synergistic efficacy in metabolic and cellular assays.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Not intended for consumption of any kind.
Certificate of Analysis
99%+
Purity
Passed full QC panel
- Purity (HPLC)
- Identity (HPLC / MS)
- Net Peptide Content
- Heavy Metals (ICP-MS)
- Sterility
- Endotoxin (USP <85>)
- Appearance
ISO/IEC 17025 Accredited
Compound Information
Technical specifications
Molecular Profile
What Is GLP1-T?
DIA-39-C20 is a dual incretin receptor agonist targeting GLP-1 and GIP receptors. It modulates glucose homeostasis and insulin secretion with synergistic efficacy in metabolic and cellular assays.
Storage Requirements
Stability Information
Lyophilized (powder)
-20°C · up to 2 years
Reconstituted
2-8°C · up to 30 days
